Drug profile · INN
helium
HELIUM, USP
helium (HELIUM, USP) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.
Drug details — helium
- US status
- approved
- Class
- —
- Route
- INHALATION
- Patents
- 16
- Programs
- 2
- Data quality
- 0.84
Quick answer
helium (HELIUM, USP) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related patents
-
US 11857697
Compositions and methods for obtaining 3-dimensional lung-like epithelium and related uses thereof
granted -
US 11441184
Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (IPSCs)
granted -
US 11261237
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection
granted -
US 10480031
Method for generating Retinal Pigment Epithelium (RPE) cells from Induced Pluripotent Stem Cells (IPSCs)
granted -
US 10081668
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection
granted -
US 9649340
Methods for producing enriched populations of human retinal pigment epithelium cells
granted -
US 9339528
Methods for treating epithelium trauma of the intestinal mucosa using interleukin-1 receptor antagonist
granted -
US 8609408
Method for the reconstruction of a tissue-engineered human corneal endothelium
granted -
US 7470659
Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM)
granted -
US 7179621
Pigment epithelium-derived factor: sequence of the PEDF gene
granted -
US 6720180
Wounded epithelium-specific transcript
expired -
US 6629970
Method of restoring endothelium of cornea
expired -
US 6451763
Retinal pigmented epithelium derived neurotrophic factor and methods of use
expired -
US 6319687
Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene
expired -
US 6153430
Nucleic acid encoding mesothelin, a differentiation antigen present on mesothelium, mesotheliomas and ovarian cancers
expired -
US 6083502
Mesothelium antigen and methods and kits for targeting it
expired
Frequently asked questions
What is helium?
helium (HELIUM, USP) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for helium?
HELIUM, USP is a marketed brand name for helium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of helium?
helium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.